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Abstract
The hematopoietic system is a distributed tissue that consists of
functionally distinct cell types continuously produced through
hematopoietic stem cell (HSC) differentiation. Combining genomic
and phenotypic data with high-content experiments, we have built
a directional cell–cell communication network between 12 cell
types isolated from human umbilical cord blood. Network structure
analysis revealed that ligand production is cell type dependent,
whereas ligand binding is promiscuous. Consequently, additional
control strategies such as cell frequency modulation and compart-
mentalization were needed to achieve specificity in HSC fate regu-
lation. Incorporating the in vitro effects (quiescence, self-renewal,
proliferation, or differentiation) of 27 HSC binding ligands into the
topology of the cell–cell communication network allowed coding of
cell type-dependent feedback regulation of HSC fate. Pathway
enrichment analysis identified intracellular regulatory motifs
enriched in these cell type- and ligand-coupled responses. This
study uncovers cellular mechanisms of hematopoietic cell feedback
in HSC fate regulation, provides insight into the design principles of
the human hematopoietic system, and serves as a foundation for
the analysis of intercellular regulation in multicellular systems.
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Introduction
The hematopoietic system is a distributed tissue consisting of multiple
phenotypically and functionally distinct cell types. Hematopoietic
stem cells (HSCs), at the apex of the hematopoietic developmental
hierarchy, populate and sustain the system through highly coordi-
nated self-renewal and differentiation processes. Increasing
evidence suggests that HSC fate decisions are regulated in part via
feedback mechanisms including HSC autocrine signaling and para-
crine signaling from differentiated hematopoietic cells (Csaszar
et al, 2012; Heazlewood et al, 2013). However, the key signaling
molecules and cell types involved and how multiple often compet-
ing feedback signals act to regulate HSC fate in a coordinated
manner are poorly understood.
We previously used mathematical modeling and bioinformatic
strategies to systematically characterize the role of feedback signal-
ing in regulating human umbilical cord blood (UCB) HSC fate in
vitro (Kirouac et al, 2009, 2010). We identified lineage-dependent
stimulatory and inhibitory signals that constitute a dynamic and
complex feedback signaling network for hematopoietic stem and
progenitor cell (HSPC) proliferation. This led to the development of
an effective culture system capable of expanding human UCB HSC
by globally diluting inhibitory feedback signals (Csaszar et al,
2012), pointing to the relevance of the network that our modeling
approach uncovered. However, how the feedback signaling network
is organized and how HSCs sense and interpret the signals produced
by different cell types remains to be elucidated.
Network analysis is a powerful approach to detect the design
principles of many types of distributed systems. This strategy has
been used to interpret ecological (Olesen et al, 2007), social
(Apicella et al, 2012), financial (Vitali et al, 2011), and molecular
(Jeong et al, 2001) systems, but has never been applied to cell–cell
communication (CCC) networks. We hypothesized that mapping the
hierarchical hematopoietic signaling network would provide insight
into its regulatory structure and function, in particular how feed-
back mechanisms control HSC fate decisions. From a network struc-
ture perspective, we were particularly interested in understanding
how network structures including modular (network division into
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sub-networks) and promiscuous (overlapping connectivity and
subspecialization of network components) strategies impact hema-
topoietic system behavior and HSC fate regulation.
Existing hematopoietic intercellular signaling networks have
been constructed based on theoretical interactions between cells
(Frankenstein et al, 2006) or curation of ligand–receptor inter-
actions in heterogeneous cell populations (Kirouac et al, 2010). By
taking advantage of high-resolution sorting of hematopoietic cells
and transcriptome profiling, we created a CCC network to represent
intercellular signaling between 12 highly resolved and phenotypi-
cally defined populations of stem, progenitor, and mature cell types
from uncultured human UCB samples. We computationally
analyzed the properties of the system and validated predictions
using in vitro HSC fate responses to network-predicted HSC-targeting
ligands. Our results support a model whereby differentiated
hematopoietic cells influence HSC fates by regulating key intracellu-
lar regulatory nodes through cell type-dependent feedback signals.
Control parameters such as relative cell frequency and local
compartmentalization (niches) are opportunities to impose specific-
ity in HSC fate regulation. Overall, our findings provide insight into
the design principles of the human hematopoietic system focusing
on the mechanisms of CCC in the feedback regulation of HSC fate.
Further, our approach provides a fundamentally new strategy for
analyzing intercellular regulation in multicellular systems.
Results
A hematopoietic cell–cell communication network is constructed
from transcriptomic data
Our strategy for constructing and analyzing hematopoietic CCC
networks is shown in Fig 1 that we will refer to throughout the
manuscript. Transcriptomic data (Novershtern et al, 2011; Laurenti
et al, 2013) of 12 phenotypically defined, highly enriched hema-
topoietic cell types (Fig 2A) were the resource for network
construction (Fig 1; step 1a). The data captured the intuitive
biological properties of corresponding cell types as defined by
gene ontology (Fig 2B; see also Supplementary Table S1 and
Materials and Methods). For example, stem and progenitor cells
(hereafter collectively referred to as the primitive cells), except for
megakaryocyte–erythroid progenitors (MEP), over-expressed HSC
proliferation and differentiation genes; MEP and erythroblasts
(EryB) over-expressed erythrocyte and megakaryocyte (Mega)
differentiation genes; monocytes (Mono) over-expressed genes
related to leukocyte and neutrophil (Neut) biological properties;
and precursor B cells (PreB) over-expressed genes related to PreB
differentiation.
To construct the CCC network, we compiled a database
(Supplementary Table S2) of 341 receptors (or receptor genes) and
their cognate ligands equivalent to 253 ligands (or ligand genes)
(Materials and Methods). Hierarchical clustering of the receptor
and ligand gene expression values recapitulated the developmental
relationship (primitive cell compartment versus mature cell
compartment) between the 12 cell types (Fig 2C), indicating simi-
lar expression of ligand and receptor genes in cells of the same
developmental stage. Specifically, the primitive cells exhibited
correlated receptor expression at higher confidence (average
P = 0.005) and correlated ligand expression at lower confidence
(average P = 0.175) than the mature cells in which average
P-values for receptor expression and ligand expression were
0.0900 and 0.0570, respectively. Thus, we suspected changes in the
receptor and ligand expression in blood cells during progression
through differentiation.
In the construction of CCC networks, we assumed that the differ-
entially over-expressed genes of each cell type are predictive of the
cell type’s protein expression (Schwanhausser et al, 2011), and
representative of the cell type’s biological properties. To determine
an appropriate false discovery rate (FDR) to define differential over-
expression, we tested FDRs of 1%, 5%, 10%, 20% and 25% and
then compared the set of receptors identified at each threshold to a
benchmark of known cell type-associated receptors (see Materials
and Methods). A FDR of 10% detected the known cell type-
associated receptors with the optimal combination of sensitivity and
specificity (Supplementary Fig S1), and thus the ligands (Supple-
mentary Table S3A) and receptors (Supplementary Table S3B)
differentially over-expressed according to this threshold were used
in the subsequent analyses (Fig 1; step 1b).
A CCC network is a directional bipartite graph (Fig 2D)
composed of connections between differentially over-expressed
ligand and receptor genes of the cell types of interest, based on
933 ligand–receptor interaction pairs (Supplementary Table S2)
involving the 341 receptors and 253 ligands in Fig 2C (Materials
and Methods for network construction). Sixteen class-1 cytokines
including CNTF, CSF2, CTF1, IL2, IL3, IL4, IL5, IL6, IL7, IL9, IL11,
IL13, IL15, IL21, LIF, and OSM require interaction with hetero-
multimeric receptors to initiate intracellular signaling cascades
(Robb, 2007). Given that our network was constructed from gene
expression data, from a modeling perspective, we assumed that
the greater the number of receptor species that a cell expresses for
a ligand, the higher the probability that the ligand binds to the
cell. We considered the interactions of each ligand and its cognate
receptors independently; this practice did not affect our conclu-
sions on network structures as shown below. Some differentially
over-expressed ligands and receptors did not have interaction part-
ners in the analyzed cell types. For example, KIT expressed on
HSC-enriched cells (HSCe: human UCB LinCD34+CD38
CD45RACD49f+CD90+/) binds to SCF, a ligand produced by
perivascular cells in the bone marrow niche (Ding et al, 2012),
which our system did not have information about. Such ligands or
receptors were connected to a hypothetical “Others” population
representing an unknown number of additional cell types that
potentially impact hematopoiesis. Based on these rules, a CCC
network containing 1,344 ligand production-binding relationships
between 249 ligand nodes and 13 cell nodes was constructed
(Supplementary Table S4), of which 178 ligands mediated the
connection between the 12 cell nodes of interest and 117 ligands
targeting HSCe (Fig 1; step 1c). This CCC network paves a new
way of depicting the hematopoietic hierarchy, and we next sought
to analyze its properties.
As a starting point for our analysis, we separated the CCC
network into two networks representing ligand production and
ligand binding, respectively. The cell types were ranked in different
orders based on the number of their interacting ligands in the two
processes (Fig 2E). Distribution of the cell types based on the
numbers of their produced ligands was approximated by a linear
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Figure 1. Computational and experimental workflow of the study.
The study is divided into network construction, analysis, and validation stages. Successive steps within each stage were alphabetically labeled. HSCe: human UCB HSC-
enriched (LinCD34+CD38CD45RACD49f+CD90+/) cells.
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function, whereas that based on the numbers of bound ligands was
approximated by a step-like function—on average, EryB, Neut, and
HSCe bound three times as many ligands as the other cell types.
This difference posed the hypothesis that cells and ligands possess
distinct interaction patterns in ligand production and binding
processes, a hypothesis we explored by analyzing the structure of
the two networks independently.
Interaction between blood cells and ligands in the ligand
production process is modular
A cell-to-ligand interaction, Aij, in the ligand production network
was defined if cell i produced ligand j. Simultaneously, clustering
the cell types and the ligands suggested that groups of ligands
were associated with subsets of cells in the network (Fig 3A).
Silhouette widths (Rousseeuw, 1987) measuring the relatedness of
the cell types’ ligand production supported the existence of 4
ligand–cell modules (Fig 3B, Supplementary Fig S2): the primitive
cell module (HSCe + MLP + CMP + MEP + GMP), neutrophil–
monocyte module (Neut + Mono), erythroid module (EryB), and a
module of all the other cell types (Boso + Eos + Mega + PreB)
(Fig 1; step 2a). A priori biological processes of 190 ligands
(Supplementary Table S5) suggested that each blood cell module
produced ligands with biased biological functions. For instance,
ligands of the neutrophil–monocyte module enriched in exoge-
neous signals that inhibit cell survival (HG Z-scores were 1.63 and
2.98 for Mono and Neut, respectively) and signals that mediate cell
survival via NF-jB (HG Z-scores were 2.15 and 1.43 for Mono and
Neut, respectively); ligands of Baso, Eos, and PreB within the
(Boso + Eos + Mega + PreB) module enriched in signals that direct
differentiation cell fates of T helper cells (HG Z-scores were 1.17,
2.65, and 3.18 for Baso, Eos, and PreB, respectively); and ligands
of EryB enriched in signals that regulate G1-S cell cycle transition
(HG Z-score = 1.41) (Fig 3C). See Supplementary Table S6 for the
other HG enrichment Z-scores.
In summary, our analysis suggested that blood cell ligand
production is peculiar to blood cell identities, and a modular inter-
action structure exists in the ligand production network. This
conclusion is robust to the choice of FDR threshold for differential
gene over-expression (Supplementary Fig S2B) and the incorpora-
tion of hetero-multimeric receptor expression in network construc-
tion (Supplementary Fig S2C). Furthermore, ligand production of
hematopoietic cell modules indicated characteristic biological prop-
erties. Considering HSC feedback regulation, this raised the possibil-
ity of HSC feedback control by cell module- or cell type-specific
signaling.
Interaction between ligands and blood cells in the ligand binding
process is promiscuous
We next sought to determine whether the ligand binding network
had a similar structure to the ligand production network. A
ligand-to-cell interaction, Bji, in the ligand binding network was
defined if cell i expressed receptor(s) for ligand j. Interrogation of
the network (Fig 4A) using spectral co-clustering (Dhillon, 2001)
suggested a significantly less modular interaction structure than in
the ligand production network (Fig 3A) (t-test P < 0.001), with
ubiquitously shared ligand binding among the 12 cell types due to
non-specific ligand–receptor interactions (Supplementary Fig S3A).
The promiscuous network structure is robust to the choice of
FDR threshold for differential gene over-expression (Supplementary
Fig S3B) and the incorporation of hetero-multimeric receptor
expression in network construction (Supplementary Fig S3C).
Interestingly, HSCe which normally reside in the bone morrow niche
with progenitor and maturing cells (Fig 4B) interacted with ligands
of the greatest diversity. This raised the question of how HSCe fate
can be specifically regulated in response to physiological demand.
We hypothesized two different mechanisms: relative cell frequency
that allows more abundant cell types skew the ligand species and
resources available to HSCe, and cell compartmentalization that
limits the access of HSCe to locally available ligands. We then
explored, computationally, the effects of the two mechanisms on the
quantity and identity of HSCe-targeting ligands (Fig 1; step 2b).
To explore the role of cell frequency in skewing HSCe-
targeting ligands, we compared ligand binding in two scenarios
by assuming that the probability of binding a ligand is a function
of cell frequency given non-regulated receptor ligand affinities. In
the first scenario, we modeled ligand binding in the system of
mono-nucleated cells (MNC) isolated from fresh human UCB
samples. Based on flow cytometry analysis, Neut was the most
abundant cell type in the system (Fig 4Ci) according to the
phenotypic definition we used; consequently, the cell type was
the major ligand sink that significantly influenced ligand accessi-
bility of the other cell types (Fig 4Cii). In contrast, HSCe, a
quantitatively underrepresented cell type in the MNC system, had
negligible ligand access despite the large number ligands targeting
the cell type (Fig 4A). In the second scenario, we modeled ligand
binding using cell frequencies from progenitor cell-enriched UCB
samples (Fig 4Di), in which cell composition is reminiscent of
the progenitor enrichment seen during development or in the
bone marrow niche (Nombela-Arrieta et al, 2013). Increased
frequency of HSCe elevated their access to the available ligand
resources (Fig 4Dii). This analysis indicates that controlling
Figure 2. Construction of cell–cell communication networks.
A Transcriptomic profiles of 12 phenotypically defined hematopoietic cell types isolated from human UCB were used. CMP, common myeloid progenitors; MEP,
megakaryocyte–erythroid progenitors; GMP, granulocyte–monocyte progenitors; EryB, erythroblasts; Mega, megakaryocytes; Neut, neutrophils; Baso, basophils; Eos,
eosinophils; Mono, monocytes; MLP, multilymphoid progenitors; PreB, precursor B cells.
B Hematopoietic gene ontology enrichment analysis. Shown is the enriched gene ontology with hypergeometric (HG) Z-scores > 1.15.
C Hierarchical relationships between the 12 cell types based on their ligand and receptor gene expression profiles. Hierarchical clusters for (i) 253 ligand genes and (ii)
341 receptor genes. Bootstrapped P-values (or approximately unbiased P-values) on the dendrograms score the uncertainty of the clusters. Dendrograms of gene
clusters are not shown.
D Concepts of cell–cell communication network constructed from differentially over-expressed ligand and receptor genes of each cell type.
E Ranks of the 13 cell types including “Others” based on the numbers of their produced ligands and the numbers of their bound ligands.
See also Supplementary Fig S1.
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hematopoietic cell relative frequency can modulate ligand expo-
sure to HSCe.
Then, we explored the role of cell compartmentalization. While an
increasing number of hematopoietic cell types such as erythroblasts
(Soni et al, 2008), megakaryocytes (Huang & Cantor, 2009), mono-
cytes (Chow et al, 2011), and B cell progenitors (Nagasawa, 2007) are
found in the stem cell niche within the bone marrow environment, the
exact location and direct feedback role of these cell types on HSC fate
decisions is not clear. We used OR gates to model the feedback effect
of these cell types on HSCe as a function of their localization based
on the extant knowledge of 190 ligands (Supplementary Table S5).
The model consisted of four compartments to represent cells of
different developmental stages: HSCe themselves, progenitor cells
(PC = CMP + GMP + MEP + MLP), mature cells in the stem cell niche
(MCN = EryB + Mega + Mono + PreB), and granulocytic mature cells
in the peripheral blood or tissues (MCP = Baso + Eos + Neut)
(Fig 4E). The spatial relationship between each compartment and
HSCe was modeled by the probability of the ligands produced by the
compartment reaching HSCe (Materials and Methods). Specifically, we
assumed that (i) there is no diffusion for HSCe autocrine ligands, so
the probability of HSCe autocrine binding PHSCe is 1; (ii) PC reside
close to HSCe, so PPC is 0.8; (iii) MCN reside further away from HSCe
than PC, so PMCN is 0.7; (iv) physical barriers between the stem cell
niche and the peripheral tissues prevent MCP ligands from reaching
HSCe, so PMCP is 0.1. We found that HSCe expressed a broad spectrum
of autocrine signals including those thought to be important for HSC
self-maintenance, whereas PC and MCN were the major producers of
non-HSC supportive signals (Fig 4F).
In vivomonocytes, megakaryocytes, erythroblasts, and pre-B cells
are primed to transit from the bone marrow to the peripheral blood.
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This cell movement potentially alters the HSC microenvironment. We
next sought to predict the spatial effect of Mono, Mega, EryB, and
PreB on HSCe feedback regulation. Our simulation results (Fig 4G)
revealed the importance of Mega-produced HSCe-targeting ligands
in innate inflammatory response terms and the importance of
Mono-produced HSCe-targeting ligands in regulating angiogenesis-
associated terms. Strikingly, it was evident that EryB-produced
HSCe-targeting ligands are associated with regulating cell cycle
progression, cell survival and proliferation, which warrants future
experimental validation. This analysis indicates that regulation of cell
identities in HSCe microenvironment or niche can modulate ligand
exposure to HSCe.
In summary, our analysis uncovered promiscuous ligand-to-cell
interactions in the ligand binding network. HSCe were found to
express receptors for a broad range of ligands, implying the exis-
tence of physical parameters such as relative cell frequency and
compartmentalization in HSC fate regulation. Our subsequent simu-
lation revealed a potential importance of Mega, Mono, and EryB
ligands in HSC fate regulation. To explore how hematopoietic cell
type-dependent signals feedback to HSCe, we next performed high-
content in vitro experiments for HSCe-targeting ligands.
Validation of HSCe-targeting ligands using a high-content in vitro
phenotypic assay
High-content in vitro experiments were performed by following the
protocol in Fig 5A. HSCe-targeting ligands in the CCC network
(Supplementary Table S4) were ranked according to the molecular
interaction confidence scores (Ceol et al, 2010) for ligand–receptor
interactions (Supplementary Table S2) and the receptor gene expres-
sion levels in HSCe from the Transcriptomic data. Thirty-three
ligands were prioritized for experimental tests (Materials and Meth-
ods, Supplementary Table S7). We examined the phenotypic impact
of each ligand on 40 HSC-enriched cells (HSC-e: LinCD34+
RholowCD38CD45RACD49f+) isolated from human UCB samples;
this population contains approximately one NOD-scid-IL2Rgc/
repopulating cell per 13 cells (combination of 1:10 for
CD49f+CD90+ and 1:20 for CD49f+CD90 HSC-enriched cells)
(Notta et al, 2011). Each ligand was tested in a short-term assay at
three doses in the presence of three basal cytokines (BC)—SCF,
THPO, and FLT3LG (Petzer et al, 1996; Madlambayan et al,
2005; Csaszar et al, 2012). On day 7, the numbers of
CD34+CD133+CD90+ cells (defined as HSC-enriched cells) (Mayani
& Lansdorp, 1994; Dorrell et al, 2000; Danet et al, 2001; Ito et al,
2010), CD34+ cells that were CD133 or CD90 (defined as progeni-
tor cells; see Supplementary Fig S5 for functional quantification
using the colony-forming cell assay), and CD34 cells (defined as
mature cells) were quantified. The BC cocktail-supplemented
culture output 704  425 (mean  s.d. from 33 biological repli-
cates) cells consisted of 6.35  3.21% HSC-enriched cells,
27.75  6.86% progenitor cells, and 65.90  10.04% mature cells.
This established a reference for detecting the effects of test ligands
on HSC-e fate decisions (Supplementary Fig S6). In addition to the
BC cocktail, TGFB1 (10 ng/ml) (Batard et al, 2000) and StemRege-
nin 1 (SR1, 0.75 lM) (Boitano et al, 2010) were used as the negative
and positive control for HSC-e expansion, respectively (Fig 5B).
In vitro effect of the 33 ligands was quantified by signed one-tail
P-values from the nested ANOVA detailed in the Materials and
Methods (Supplementary Fig S7A). P-values of the 35 ligands
(including TGFB1 and SR1) at their most effective dose on human
UCB HSC-e are shown in Fig 5C. For ligands that did not have any
significant effect, results of the highest working concentrations were
reported. See Supplementary Fig S8 for cell number comparison
between the tested conditions and the BC control. See Supplemen-
tary Tables S8 and S9 for results of all the testing conditions. These
in vitro data allowed us to examine the impact of the cell types of
interest on HSC fate regulation in the CCC network.
Provisional feedback signaling networks for cell type-associable
HSC fate modulation
Measurement of the in vitro effect of the 33 ligands on HSC-e
allowed creation of a directional CCC network. First, we categorized
each ligand into one of the five functional categories [inducing
quiescence, inducing self-renewal, inducing differentiation, inducing
proliferation (self-renewal + differentiation), and inhibiting prolifer-
ation] in terms of their manipulation in HSC-e fate decisions using
the P-values in Supplementary Table S9 and the classifier in
Table 1. A representative ligand is given for each category in
Supplementary Fig S7B. The ligands, at the working concentrations
shown in Fig 5C, were categorized with different confidences
(Fig 6A). Collectively, 27 out of the 33 ligands of interest were
Figure 4. Promiscuous ligand–cell interaction structure in the ligand binding network.
A Spectral co-clustered adjacency matrix of ligand-to-cell interactions. The gray scale indicates the number of receptor genes expressed by a cell type for each of the
178 ligands.
B Schematic in vivo HSCe feedback signaling network.
C Cell frequency-dependent ligand binding network in the mono-nucleated cell compartment. (i) Composition of mono-nucleated cells isolated from fresh human UCB
samples (n = 3). (ii) Potential of apparent competition (PAC) computed from the network weighted by the cell composition shown in (i). Along the edge connecting
node i and node j, the width at node i indicates the competitiveness of node i to node j in terms of ligand binding.
D Cell frequency-dependent ligand binding network in the stem and progenitor cell compartment. (i) Cell frequencies in lineage-depleted cells isolated from uncultured
human UCB samples (n = 3). (ii) PAC computed from the network weighted by the cell composition shown in (i).
E Logic gates used to model in vivo HSCe feedback signaling. The probability (P) of a cell compartment feeding signals to HSCe is inversely proportional to the distance
between the cell compartment and HSCe.
F Simulated functional effect of HSCe, PC, MCN, and MCP on HSCe as a function of feedback probability P. The color map indicates average signaling strength from 500
simulations. Insignificant cell–cell communication is colored in gray.
G Simulated functional contribution of MCN cell type x (Mega, Mono, EryB, or PreB) to HSCe-targeting ligands as a function of the distance between MCN cell type x
and HSCe. The simulation was performed at PHSCe = 1, PPC = 0.8, PMCN-not x = 0.7, and PMCP = 0.1. The magnitudes of contribution are with respect to PMCN-x = 0,
which is set to 0.
See also Supplementary Figure S3.
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found to direct HSC-e fate decisions (Fig 1; step 3a), indicating a
significant enrichment of prediction capacity in this analysis
(Binomial P = 0.0001, Materials and Methods).
Intriguingly, dose-dependent HSC-e fate regulation was observed
for some ligands. For example, TNFSF10, at a working concentra-
tion of 1 ng/ml, did not affect the number of HSC-enriched cells,
progenitor cells, or mature cells (ANOVA P-values were 0.2747,
0.2642, and 0.3721, respectively). When the ligand was used at
10 ng/ml, it led to an increase in the number of HSC-enriched cells
(ANOVA P = 0.0036), so it induced HSC-e self-renewal. At a work-
ing concentration of 100 ng/ml, however, the ligand led to a signifi-
cant decrease in the number of HSC-enriched cells (ANOVA
P = 0.0007), progenitor cells (ANOVA P = 0.0094), and mature cells
(ANOVA P = 0.0207) (Supplementary Fig S6Bii), so it inhibited
HSC-e proliferation, which may be due to the pro-apoptotic effect
of the ligand (Zamai et al, 2000). Dose-dependent HSC-e fate
regulation was also observed for FGF1, FGF2, IL11, and TNFSF12
(Supplementary Table S9). This result is reminiscent of differential
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and 100 ng/ml FLT3LG.
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See also Supplementary Figs S4, S5 and S6.
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activation of pathways that are involved in diverse biological
processes (Kale, 2004). Furthermore, categorization of some ligands
such as FGF2 (working concentration, WC = 50 ng/ml) and BMP6
(WC = 100 ng/ml) was sensitive to the statistical significance
threshold, suggesting their indeterminate role in regulating HSC-e
fate decisions may be context dependent. The ligands were excluded
accordingly in the subsequent analyses.
We explored how ligands produced by different cell types influ-
enced HSC-e fate decisions by performing a functional enrichment
analysis for the ligands expressed by each of the 12 cell types in the
CCC network using the ligand function categorization (Fig 6A) as a
reference. To ensure that there were sufficient data to draw qualita-
tive conclusions, the analysis was performed based on the categori-
zation at the intermediate confidence level while excluding BMP6 in
which categorization was indeterminate at that confidence level.
Assuming each ligand acts independently in HSC-e fate regulation,
this analysis allowed us, for the first time, to predict the role of each
cell type in the HSC-e feedback regulation. As shown in Fig 6B,
progenitor cells such as CMP, MEP, GMP, and MLP predominantly
expressed ligands that induced HSC-e quiescence and self-renewal;
EryB expressed ligands of diverse functions as expected from the
results shown in Fig 3C. In contrast to a majority of the cell types,
which expressed at most three types of directive signals for HSC-e fate
decisions, HSCe expressed ligands inducing self-renewal, quiescence,
and differentiation, and inhibiting proliferation. This is reminiscent of
self-sufficient autocrine signaling of HSC (Kirito et al, 2005) possibly
to compensate for their disadvantage in accessing exogenous signals
Table 1. Functional definition of ligands for HSC-e fate regulation
based on a cell number comparison between the conditions having the
ligands of interest and the basal cytokine control.
HSC-enriched
cells
Progenitor
cells
Mature
cells
Neutral – – –
Quiescence induction – – ↓
– ↓ –
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↑ – –
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↓ – ↓
↓ – –
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See also Supplementary Figs S7 and S8.
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due to low cell frequency (Fig 4Ci). Collectively, we propose that
both the progenitor cells and the mature cells regulate HSC-e fate deci-
sions via feedback signaling yet through different mechanisms—the
progenitor cells feed back HSC-e self-renewal and quiescence signals,
whereas the more mature cells feed back HSC-e predominantly
proliferation and differentiation signals (Fig 1; step 3b).
Pathway enrichment analysis suggested intracellular regulatory
motifs for HSC-e fate decision-making
The association between HSCe-targeting ligands and different cell
types allowed us to construct a qualitative CCC network focusing on
HSC-e fate regulation (Fig 7A). A database survey on the intracellular
signaling pathways of the HSCe-targeting ligands suggested that
intracellular regulatory motifs are associable with the ligands
responsible for directive effects on HSC-e cell fate decisions in vitro
(Fig 7B, Supplementary Fig S9, Materials and Methods). Specifically,
signaling activity of the HSC-e quiescence-inducing ligands (such
as BMP6 and IHNBA), self-renewal-inducing ligands (such as
ANGPT1, ANGPT2, NGF, and TNFSF12), proliferation-inducing
ligands (such as CSF2, CSF3, and IL11), and proliferation inhibitory
ligands (such as TGFB1, TNFSF10, and TNF) were attributable to
SMAD (permutation P = 0.044, Supplementary Fig S9A), NF-jB
(permutation P = 0.122, Supplementary Fig S9C), STAT (permutation
P = 0.04, Supplementary Fig S9C), and caspase cascade (permutation
P = 0.059, Supplementary Fig S9D) pathways, respectively.
Our qualitative CCC network can be depicted in three ways: a
directional network weighted by receptor frequency (Fig 7C), a
directional network weighted by cell frequencies in the MNC
compartment (Fig 7D), and a weighted directional network with
compartmentalization (Fig 7E) overlaid to illustrate the roles of
cellular dynamics and spatial distribution in HSC fate regulation
through feedback signaling. For example, Neut was the largest cell
population in the MNC isolated from human UCB (Fig 4C), so
TNFSF10 and TNF from Neut were potentially the major signals to
inhibit HSC-e proliferation. However, the stem cell niche-peripheral
barrier would typically protect HSC-e from the inhibitory signals.
In summary, we combined the topology of the CCC network, the
in vitro effect of 33 ligands on HSC-e fate decisions, and pathway
information of the ligands. Our results support a model whereby
hematopoietic cells influence HSC toward certain cell fates by regu-
lating the key intracellular regulatory motifs through cell type-
specific feedback signals.
Discussion
While it is accepted that feedback regulation of HSC fate decisions
is important to stable hematopoiesis (Csaszar et al, 2012;
Heazlewood et al, 2013), it has been unclear how the feedback
system operates. Extensive effort has been made to understand how
stromal cells in the bone marrow microenvironment regulate HSC
fate decisions (Zhang et al, 2003; Nakamura et al, 2010; Kunisaki
et al, 2013). In addition, we propose a hematopoietic cell-driven
feedback system that regulates HSC fate decisions through inter-
cellular signaling.
We constructed a bipartite graph to represent the CCC network
between 12 hematopoietic cell types isolated from human UCB (and
orphan signals entering the network). We found that the CCC network
can be depicted in two formats based on signal directionality—
ligand production and ligand binding, and each format was
analyzed as an individual network. The high degree of modularity
in the ligand production network pointed to cell type-specific
production of ligands for HSC-e cell fate regulation. In contrast, the
ligand-to-cell interactions in the ligand binding network were
promiscuous, and HSCe were one of the cell types that bound the
most ligands, suggesting that HSCe have broad environment sensing
capacity (Takizawa et al, 2012). Our analysis raised important ques-
tions about how feedback specificity is achieved in HSC fate regula-
tion. In silico simulation posed the hypothesis that additional
control mechanisms including those observed in vivo (cell type
frequency control and HSC niche localization or compartmentaliza-
tion) are required to confer specificity in hematopoietic cell-
mediated feedback regulation of HSC fate decisions. To test the
hypothesis, we prioritized 33 HSCe-targeted ligands in the CCC
network for in vitro experiments. We anticipated the roles of the 33
ligands in directing HSC-e fate decision using a cell surface marker
expression-based phenotypic assay. The in vitro data allowed us to
uncover what signals each of the 12 cell types feeds back to HSC-e.
For instance, the mature cells, particularly Mono and granulocytes
(Neut, Baso, and Eos), were found to express mainly inhibitory
signals for HSC-e proliferation and inducing signals for HSC-e differ-
entiation, which in combination can exhaust the HSC population
because of the extensive cell cycling and division involved in the
proliferation and differentiation processes (Hock et al, 2004; Zhang
et al, 2006). However, under a normal in vivo condition, monocytes
and granulocytes mainly circulate in the peripheral tissues; their
secreted ligands have limited access to HSC in the bone marrow
compartment because of the blood–bone marrow barrier. The identi-
fied importance of cell compartmentalization in protecting HSC from
exogenous signals is consistent with our observation that global
media dilution enhances in vitro HSC production when physical
barriers between HSC and the mature cells are absent (Csaszar et al,
2012). We also found that progenitor cell types—CMP, MEP, GMP,
and MLP—that typically co-localized with HSC in the bone marrow
niche tend to function as a unit, enriched for ligands for HSC mainte-
nance by inducing HSC quiescence and self-renewal. This finding
supports the use of periodic primitive cell selection to increase in vitro
HSC production (Madlambayan et al, 2005) and suggests technologies
that target the HSC niche composition to control HSC fate in vivo.
The pathway enrichment analysis pointed to specific intracellular
regulatory motifs associated with ligands of different in vitro effects
on HSC-e fate. Specifically, HSC-e quiescence-inducing ligands such
as BMP6 (Holien et al, 2012) and INHBA (Burdette et al, 2005)
regulate the expression of SMADs to arrest cell growth. The HSC-e
self-renewal-inducing ligands such as angiopoietins (Hughes et al,
2003), NGF (Descamps et al, 2001), and TNFSF12 (Kawakita et al,
2004) were found to regulate the activity of NF-jB in which deletion
in the mouse hematopoietic system compromised the self-renewal
and long-term hematopoietic repopulation ability of HSC (Zhao
et al, 2012; Stein & Baldwin, 2013). The HSC-e proliferation-inducing
ligands such as CSF2 (Carter, 2001; Gu et al, 2007), CSF3 (Harel-
Bellan & Farrar, 1987), and IL11 (Yoshizaki et al, 2006) were found
to induce the expression of STATs for cell proliferation. Finally, the
HSC-e proliferation inhibitory ligands such as TGFB1 (Shima et al,
1999), TNF (Mallick et al, 2012), and TNFSF10 (Kischkel et al,
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2000) initiated caspase cascade to cause cell death. Although many
connections between exogeneous ligand stimulation, pathway node
activity, and cell phenotype changes were established in cancer cell
lines, these connections led us to the anticipation that exogeneous
ligands direct HSC-e toward different cell fate by regulating the
activity of specific cell fate decision-associated intracellular regula-
tory motifs, which opens opportunities for future study.
In summary, our results demonstrate the importance of cell-to-
cell communication in human UCB stem cell fate control. Hemato-
poietic cells influence HSC toward certain cell fates by regulating
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the key intracellular regulatory motifs through cell type-specific
feedback signals. Further, control parameters such as relative cell
frequency and spatial compartmentalization (niches) are opportuni-
ties to impose specificity in HSC fate regulation. A particularly inter-
esting extension of our current work is to analyze how defects in
HSC niche composition and physical structure or defects in HSC
intracellular regulatory motifs affect feedback regulation of HSC fate
decisions in vivo and consequently causes hematopoietic disorders
such as leukemogenesis (Schepers et al, 2013).
One limitation of this study is that we used only transcriptomic
data rather than proteomic data to construct the CCC network.
Although there is a general agreement between mRNA and protein
expression levels of ligands and receptors in mammalian cells (De
Haan et al, 2003; Madlambayan et al, 2005; Schwanhausser et al,
2011), gaining better understanding of the dynamics of mRNA
expression and the corresponding protein expression can be impor-
tant in understanding context-specific network structures and their
dynamic evolution. The newly developed mass cytometry (Bendall
et al, 2011) offers a novel single cell proteomic approach to achieve
this goal. A second limitation of this study is that we defined the
exogenous effects of 33 ligands on HSC-e fate decision according to
in vitro measurements of a cell surface marker expression-based
phenotypic assay. Discrepancy between our observation about the
in vitro effects of the tested ligands and their documented effects in
literature may be attributable to the differences in experimenting cell
populations and culture conditions. Further functional validation of
the surface markers to cell function fidelity would certainly strengthen
our analysis of network directionality; ultimately, our network should
guide the selection of potentially novel HSC-e-regulating cell types,
ligands, and their key intracellular signaling nodes for in-depth
in vivo characterization. A final limitation of this study is that we
used a static (human UCB) network to predict potentially dynamic
feedback relationships between HSC-e and the other cell types.
Exploring how the network connections change during culture
evolution (Qiao et al, 2012) is an important next step. The assump-
tion of our static network is direct (as opposed to indirect) feedback
from each cell type to HSC-e. Although our in vitro study was specifi-
cally designed to enrich for direct effects of ligands on HSC-e by
using the HSCe receptor expression information as a criterion for
selecting test ligands and using a short culture time (7 days) (Csaszar
et al, 2014), further analysis of multi-step and adaptive feedback is
needed to strengthen links to in vivo hematopoiesis.
Collectively, cell–cell communication is fundamental to biologic
tissues. However, it has not been extensively explored as a network
because a large number of underpinning variables need to be
considered. Here, we provide a framework to systematically depict
cell–cell communication as a network while exploring the roles of
cell frequency and spatial distribution in the system. As a next step,
connecting the CCC network with more widely studied protein–
protein interaction (Kirouac et al, 2010) and gene regulatory
(McKinney-Freeman et al, 2012) networks through mechanistic
models of intracellular signaling activity and the resulting cellular
responses (Janes et al, 2005) will allow us to understand how HSCs
integrate exogenous signals to make fateful decisions. The outcome
will not only contribute to the development of more effective
methods for HSC production, but also further our knowledge about
HSC (niche) biology and cell–cell communication as a layer of
biological regulation.
Materials and Methods
Microarray datasets
Illumina data of primitive cells and progenitor B cells (ProB:
CD34+CD10+CD19+; three biological replicates) were obtained
from the authors of Laurenti et al (2013). The primitive cells are
HSCe (LinCD34+CD38CD49f+CD45RACD90+/; 10 biological
replicates), CMP (LinCD34+CD38+CD135+CD45RACD7CD10;
five biological replicates), MLP (LinCD34+CD38CD90CD45RA+;
five biological replicates), MEP (LinCD34+CD38+CD135
CD45RACD7CD10; five biological replicates), and GMP
(LinCD34+CD38+CD135+CD45RA+CD7CD10; five biological
replicates). The data are accessible at Gene Expression Omnibus
(GEO) (Edgar et al, 2002) through accession number GSE42414.
Quantile signals of the Illumina data were calculated using the
normalizeQuantile() function in the limma package (v3.16.3) of
BioConductor.
Affymetrix CEL files of mature cells and ProB
(CD34+CD10+CD19+; five biological replicates) were downloaded
from GEO (accession number GSE24759 (Novershtern et al, 2011),
accessed on 2011-11-20). The mature cells are Mega (CD34CD41+
CD61+CD45; six biological replicates), EryB (CD34CD71GlyA+;
six biological replicates), Neut (FSChiSSChiCD16+CD11b+; four
biological replicates), Baso (FSChiSSCloCD22+CD123+CD33+/
CD45dim; six biological replicates), Eos (FSChiSSCloCD123+
CD33dim; five biological replicates), Mono (FSChiSSCloCD14+
CD45dim; five biological replicates), and PreB (CD34CD10+CD19+;
three biological replicates). Quality of the Affymetrix arrays was
assessed using the simpleaffy (v2.32.0) and AnnotationDbi
(v1.18.4) packages of BioConductor. The arrays with average back-
ground more than 2 s.d. from the mean background level of all
arrays and the arrays with present percent is less than 1.5 s.d. from
the mean present% of all arrays were not used for this study.
Robust multi-array average (RMA) signals of the selected arrays
were computed using the justRMA() function in the limma package
(v3.16.3) of BioConductor. Affymetrix annotation for GeneChip
U133AAofAv2 (GEO accession number: GPL4686) was used.
To combine the Illumina and the Affymetrix datasets, each
dataset was normalized by the averaged gene expression signal
of the respective ProB arrays. An averaged signal was calculated
for probes of the same gene according to Entrez gene identifiers.
The post-processed datasets were merged by Entrez gene
identifiers.
Ligand functional enrichment analysis
For the gene set enrichment analysis (GSEA) in Fig 2B, 13 hemato-
poietic gene sets (Supplementary Table S1) were compiled from the
GeneGO database on 2012-11-15. GSEA was performed using
the GSEA software (v2, http://www.broadinstitute.org) with the
minimum gene set size equal to 1, and the other settings as defaults.
See Supplementary Table S1 for GSEA Z-scores.
For the biological process enrichment analysis in Figs 3C and 4F,
gene sets in Supplementary Table S5 were curated from the Meta-
Core pathway database (http://thomsonreuters.com/metacore/,
accessed on 2014-03-05). The material is reproduced under a license
from Thomson Reuters; it may not be copied or re-distributed in
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whole or in part without the written consent of the scientific busi-
ness of Thomson Reuter.
Ligand/receptor database
Using gene ontology terms “cytokine activity,” “growth factor activ-
ity,” “hormone activity,” and “receptor activity,” 417 genes with
ligand activity and 1,723 genes with receptor activity were compiled
from BioMart (Kasprzyk, 2011) (accessed on 2012-02-29). Ligand–
receptor interaction pairs documented in public domains were
compiled using the iRefWeb (Turner et al, 2010) resource (accessed
on 2012-03-05). Additional 38 ligand–receptor interaction pairs from
literatures (as on 2013-02-04) were included. See Supplementary
Table S2 for the resulting 933 ligand–receptor interaction pairs.
Hierarchical clustering
The hierarchical clusters in Fig 2C were obtained using the Ward
agglomeration method with the Manhattan distance matrix. Confi-
dence of the clusters was quantified by approximately unbiased
(AU) P-values (Shimodaira, 2002, 2004), a type of bootstrap
P-values, computed using the pvclust package (v1.2-2) in R (v3.0.0).
Identification of differentially over-expressed genes
For the cell type of interest, one-way pairwise Wilcoxon test (R,
v2.15.1) was performed between the gene expression profiles of the
interested cell type and the profiles of each of the other cell types.
P-values were adjusted using the Benjamini & Hochberg method (or
false discovery rates, FDR). At a given threshold, the ligand and
receptor genes that differentially over-expressed comparing to six
other cell types (the threshold was set arbitrarily) were defined as
the differentially over-expressed ligands and receptors of the cell
type. The identified receptors of each cell type were compared to
hematopoietic cell type-specific receptors using receiver operating
characteristic (Supplementary Fig S1). The cell type-specific recep-
tors are (1) ACVRL1 (for TGFB1), ENG (for TGFB1), EPOR (for
KIT), FKBP1A (for TGFB1), IL2RG (for IL7), IL7R (for IL7), ITGAV
(for TGFB1), ITGB6 (for TGFB1), ITGN8 (for TGFB1), KIT (for
KITLG), LTBP1 (for TGFB1), LTBP4 (for TGFB1), MPL (for THPO),
TGFBR1 (for TGFB1), TGFBR2 (for TGFB1), TGFBR3 (for TGFB1),
VTN (for TGFB1), CD34 and ITGA6 (CD49f) for HSCe; (2) IL3RA
(for IL3), CSF2RA (for CSF2), CSF2RB (for CSF2), CSF3R (for CSF2),
EPOR (for KIT), KIT (for KIT), MPL (for THPO), CD34, CD38, FLT3
(CD135) for CMP; (3) MPL (for THPO), EPOR (for EPO), CD34 and
CD38 for MEP; (4) CSF3R (for CSF3), CD34, CD38, FLT3, PTPRC
(CD45RA) for GMP; (4) IL2RG (for IL7), IL7R (for IL7), CD34,
PTPRC (CD45RA) for MLP; (5) MPL (for THPO), ITGA2B (CD41),
ITGB3 (CD61) for Mega; (6) EPOR (for EPO), GYPA (CD235a) for
EryB; (7) CD14 for Mono; (8) CD22 and IL3RA (CD123) for Baso;
(9) IL3RA (CD123) for Eos; (10) FCGR3A (CD16) and ITGAM
(CD11b) for Neut; and (11) IL2RG (for IL4), IL4R (for IL4), IL13RA1
(for IL4), MME (CD10), and CD19 for PreB.
Network construction
Directionality of the CCC network was defined by the expression of
ligand and receptor genes on the cell types of interest, and the
ligand–receptor pairs in Supplementary Table S2. If “Cell A”
expresses a receptor for ligand x and “Cell B” expresses ligand x, an
arrow is drawn from “Cell B” to “Cell A.” Networks were built in R
(v2.15.1) and visualized in Cytoscape (v2.8.3). The R code is avail-
able upon request.
Bipartite network analysis
Clustering for the ligand production networks was performed based
on Jaccard distances appropriate for binary graph adjacency matri-
ces (Gower & Legendre, 1986). Clustering for the ligand binding
networks was performed using the spectral co-clustering algorithm
(downloaded from http://adios.tau.ac.il/SpectralCoClustering/ on
2013-06-01) appropriate for weighted graph adjacency matrices
(Dhillon, 2001).
Potential of apparent competition (Muller et al, 1999) of cell type
i to cell type j, Pij, was computed as
Pij ¼
X
K
fiRikP
I
fiRil
fjRjkP
M
fmRmk
0
@
1
A;
where fi is the normalized cell frequency of cell type i by the total
cell frequency of the analyzed cell types, thus fi is between 0 and
1; Rik is the number of receptors that cell type i expressed for
ligand k; K is the total number of ligands that cell type i binds; I is
the total number of ligands that cell type i binds; and M is the total
number of cell types that ligand k binds. The figures were drawn
by modifying the plotPAC() function in the bipartite package
(v1.18) in R (v.3.0.0).
Network comparison
To compare interaction patterns between the network of ligand
source and the network of ligand sink, for each network, the
numbers of overlapped ligands between one module and the other
modules were obtained. The overlap of ligands between modules in
the network of ligand source S = {9, 13, 10, 12, 12, 17}, and the
overlap of ligands between modules in the network of ligand sink
T = {75, 75, 69}. Two-sample t-test was performed for S and T in R
(v3.0.0).
Flow cytometry analysis
Human UCB samples were collected from consenting donors accord-
ing to ethically approved procedures at Mt. Sinai Hospital (Toronto,
ON, Canada). Mono-nucleated cells were obtained by depleting red
blood cells (RBC) using RBC lysis buffer (0.15 M NH4Cl, 0.01 M
KHCO3, 0.1 mM EDTA) as previously described (Kirouac et al,
2009). Lineage-negative (Lin) cells were isolated from the
mono-nucleated cell fraction using the StemSep system or the
EasySep system for human progenitor cell enrichment (StemCell
Technologies, Inc., Vancouver, BC, Canada), according to the manu-
facturer’s protocol. Cell frequencies shown in Fig 4Ci and 4Di were
obtained from mono-nucleated cells of fresh UCB samples and
thawed Lin cell samples, respectively. The cells were stained using
the following antibodies in 1:100 unless stated otherwise: CD90
(FITC, 1:50), CD38 (PE, PECy5, APC), CD45RA (1:50, APC), CD34
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(PE-Cy7), CD49f (PE-Cy5, 1:50), CD7 (FITC), CD10 (FITC), CD135
(1:50, PE), CD45RA (1:50, APC), CD71 (FITC), CD235a (PE), CD61
(FITC), CD41 (PE), CD45 (PE-Cy7), CD14 (PE), CD16 (PE), CD11b
(PE-Cy7), CD22 (FITC), CD33 (PE), CD123 (PE-Cy5), CD19 (FITC),
and CD10 (PE). All the antibodies were from BD Biosciences, Missis-
sauga, ON, Canada.
Logic modeling
The effect of cell localization on the identity of HSCe-targeting
ligands MHSCe was simulated using an OR gate model:
MHSCe ¼ ðxHSCe LHSCeÞ[ ðxPC LPCÞ[ ðxMCN LMCNÞ[ ðxMCP LMCPÞ;
where LHSCe, LPC, LMCN, and LMCP are the differentially over-
expressed ligands of HSCe, progenitor cells (CMP, GMP, MEP,
and MLP), mature cells in the stem cell niche (MCN), and mature
cells in the peripheral tissues (MCP). Randomly generated logic
vectors xHSCe, xPC, xMCN, and xMCP represented the probability
(PHSCe, PPC, PMCN, and PMCP) of the ligands of each compartment
to reach HSCe. Enrichment (E) of HSCe-targeting ligands MHSCe in
a biological process mediated by ligand set B was quantified as
following:
E ¼ nðMHSCe ^ BÞ
nðBÞ ;
where n(MHSCe ^ B) is the number of HSCe-targeting ligands in
biological process B, and n(B) is the number of ligands in biologi-
cal process B. For each test condition (i.e., combination of PHSCe,
PPC, PMNC, and PMCP), enriched scores from 500 simulations were
averaged. Content of 11 manually curated ligand sets of biological
processes are tabulated in Supplementary Table S5.
In vitro experiments
Human Lin cells were isolated from UCB samples collected from
consenting donors according to ethically approved procedures at
Mt. Sinai Hospital (Toronto, ON, Canada). Forty Lin
RholowCD34+CD38CD45RACD49f+ cells were sorted and
dispensed per well in a 96-well V-bottom plate with a MoFloXDP
flow cytometer (Beckman Coulter). The cells were cultured in a
serum-free condition supplemented with 100 ng/ml SCF, 100 ng/ml
FLT3LG, 50 ng/ml THPO, and a test ligand at specific concentration.
On day 7, cells were stained. Total cell counts (NTotal),
CD34+CD133+CD90+ cell counts (NHSC-enriched), and CD34
 cell
counts (NMature) were obtained using an LSRFortessa flow cytometer
(BD Bioscience). Progenitor cell counts were calculated as
NTotal  NHSC-enriched  NMature. See also “optimization of in vitro
experiments” in the Supplementary Information S1.
Statistical analysis
To assess the effects of each test ligand (in addition to SCF, THPO
and FLT3LG) on in vitro HSC-e fate decisions, a mixed-linear model
was constructed with the experiment identifier as the random effect
to account for the variability from experiment to experiment.
The analysis was performed using the lme() function of the nlme
package (v3.1-113) in R (v2.15.1). The source code is provided as
Supplementary Information S1.
Since we were mostly concerned with not missing any effective
ligands (type II error) that will inform future research, nominal
P-values of the mixed model were reported without correction for
multiple tests. The ligands were categorized using definition in
Table 1. Ligand categorization was performed for significance
P-value thresholds of 0.01, 0.02 and 0.05 (Supplementary Table S9).
See also “statistical analysis for in vitro experiments” in the
Supplementary Information S1.
At the P-value threshold of 0.02, 5 ligands were found to be
neutral to HSC-e and 27 were categorized into five functional cate-
gories (inducing HSC-e quiescence, self-renewal, differentiation and
proliferation, and inhibiting HSC-e proliferation). Assuming the
probability that a selected ligand is functional is 0.5 and that
the effectiveness of test ligands was independent from each other,
the ligand selection process was modeled as a binomial process with
distribution X~B(33, 0.5), where 33 is the number of test ligands.
The expected number of effective ligands was 33*0.5  16. The
probability of having 27 effective ligands is
PðX ¼ 27Þ ¼ 33
27
 
0:527ð1 0:5Þ6  0:0001
Prior to the in vitro experiments for testing the activity of HSCe-
targeting ligands on HSC-e, we sought to prioritize ligands for exper-
iments. To do that, we performed a literature survey on ligands that
had been used in in vitro cell culture of human cord blood-derived
cells; 11 ligands fell in this category (Supplementary Table S7).
Ligands such as ANGPT1, ANGPT2, ANGPTL3, and BMP2 had been
used in mice or human bone marrow cells (Supplementary Table
S7), so they were also prioritized for experiments in our study.
Excluding these ligands from our analysis, 15 ligands out of 18
tested ligands were effective. The corresponding probability is
PðX ¼ 27Þ ¼ 18
15
 
0:515ð1 0:5Þ3  0:003
To dictate the respective regulatory effects of HSCe, CMP, GMP,
MEP, MLP, Mega, EryB, Mono, Neut, Eos, Baso, PreB, and Others
on HSC-e cell fates, the tested ligands of each cell type were
extracted from the CCC network in Supplementary Table S4. Func-
tional enrichment analysis was performed for each cell type using
hypergeometric Z-scores,
Z ¼ k n
m
Nffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
nmN
Nm
N
 
Nn
N1
 q ;
where N = 117 is the number of HSCe-targeting ligands expressed
by the 13 cell types, m is the number of ligands in a given function
group, n is the number of expressed ligands of the cell type of
interest, and k is the number of expressed ligands in the function
group of interest.
Functional HSC-e feedback signaling network
In Fig 7C, strength of the produced signals of function group k from
cell type i to HSC-e was modeled as
ª 2014 The Authors Molecular Systems Biology 10: 741 | 2014
Wenlian Qiao et al Hematopoietic cell–cell communication network Molecular Systems Biology
15
Si;k ¼ fi
XN
n¼1
RHSCe;k;n;
where fi is the frequency of cell type i, n is the number of
expressed ligands of function group k by cell type i, and R is the
expression level of receptor gene n. Cell frequencies are from
Fig 4Ci.
Pathway analysis
Intracellular regulatory factors downstream of 16 out of the 19
ligands shown in Fig 7A are available in the MetaCore database
(http://thomsonreuters.com/metacore/, accessed on 2014-04-01).
The regulatory factors of each ligand were compiled and compared
to the regulatory factors of the other ligands of the same functional
group. Enrichment of ligands of the same functional group to each
regulatory factor was calculated by a permutation test. For each
regulatory factor, random functional categorization (quiescence
induction, self-renewal induction, proliferation induction, and
proliferation inhibition) was performed for 100,000 times. The ratio
between the number of times that a regulatory factor randomly fell
in a functional category more frequent than the actual categoriza-
tion and 100,000 is defined as the permutation P-value. The results
of pathway analysis for HSC-e differentiation-inducing ligands are
not presented because pathway information was only found for one
differentiation-inducing ligand BMP4, and the data are not sufficient
for an enrichment analysis. The material from the MetaCore path-
way database is reproduced under a license from Thomson Reuters.
Supplementary information for this article is available online:
http://msb.embopress.org
Acknowledgements
WQ was supported by Ontario Graduate Scholarships and a National Science
and Engineering Research Council postgraduate scholarship. WW was
supported by an Ontario Stem Cell Initiative post-doctoral fellowship. EL was
supported by the Swiss National Science Foundation, Roche, and the FSBMB
(Foundation Suisse pour les Bourses en Médecine et Biologie). This work was
supported by grants to SJW from the Canadian Institutes of Health Research,
the Ontario Research Fund, and the SickKids Foundation; grants to GDB from
NRNB (U.S. National Institutes of Health, National Center for Research
Resources Grant Number P41 GM103504); grants to JED from Genome Canada
through the Ontario Genomics Institute, Ontario Institute for Cancer Research,
and a Summit Award with funds from the province of Ontario, the Canadian
Institutes for Health Research, a Canada Research Chair, the Princess Margaret
Hospital Foundation, the Terry Fox Research Institute, Canadian Cancer Soci-
ety Research Institute, and in part by the Ontario Ministry of Health and Long
Term Care (OMOHLTC, the views expressed do not necessarily reflect those of
the OMOHLTC); and grants to PWZ from the Human Frontier Science Program,
the Leukemia and Lymphoma Society of Canada, the Canadian Stem Cell
Network, and the Ministry of Research and Innovation of Ontario. PWZ is the
Canada Research Chair in Stem Cell Bioengineering. The authors would like to
thank the members of the PWZ laboratory and Dr. Daniel Kirouac for their
helpful discussion.
Author contributions
WQ and PWZ conceived and designed the study and wrote the manuscript.
WQ performed in silico studies and analyzed in vitro data. WW performed in
vitro experiments and contributed to drafting the manuscript. EL, ALT, SJW, GB
and JED contributed reagents/materials/analysis tools. All the authors reviewed
the manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
References
Apicella CL, Marlowe FW, Fowler JH, Christakis NA (2012) Social networks and
cooperation in hunter-gatherers. Nature 481: 497 – 501
Batard P, Monier MN, Fortunel N, Ducos K, Sansilvestri-Morel P, Phan T,
Hatzfeld A, Hatzfeld JA (2000) TGF-(beta)1 maintains hematopoietic
immaturity by a reversible negative control of cell cycle and induces CD34
antigen up-modulation. J Cell Sci 113(Pt 3): 383 – 390
Bendall SC, Simonds EF, Qiu P, el Amir AD, Krutzik PO, Finck R, Bruggner RV,
Melamed R, Trejo A, Ornatsky OI, Balderas RS, Plevritis SK, Sachs K, Pe’er
D, Tanner SD, Nolan GP (2011) Single-cell mass cytometry of differential
immune and drug responses across a human hematopoietic continuum.
Science 332: 687 – 696
Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR,
Flaveny CA, Perdew GH, Denison MS, Schultz PG, Cooke MP (2010) Aryl
hydrocarbon receptor antagonists promote the expansion of human
hematopoietic stem cells. Science 329: 1345 – 1348
Burdette JE, Jeruss JS, Kurley SJ, Lee EJ, Woodruff TK (2005) Activin A mediates
growth inhibition and cell cycle arrest through Smads in human breast
cancer cells. Cancer Res 65: 7968 – 7975
Carter BZ (2001) Cytokine-regulated expression of survivin in myeloid
leukemia. Blood 97: 2784 – 2790
Ceol A, Chatr Aryamontri A, Licata L, Peluso D, Briganti L, Perfetto L,
Castagnoli L, Cesareni G (2010) MINT, the molecular interaction database:
2009 update. Nucleic Acids Res 38: D532 –D539
Chow A, Lucas D, Hidalgo A, Mendez-Ferrer S, Hashimoto D, Scheiermann C,
Battista M, Leboeuf M, Prophete C, van Rooijen N, Tanaka M, Merad M,
Frenette PS (2011) Bone marrow CD169+ macrophages promote the
retention of hematopoietic stem and progenitor cells in the mesenchymal
stem cell niche. J Exp Med 208: 261 – 271
Csaszar E, Kirouac DC, Yu M, Wang W, Qiao W, Cooke MP, Boitano AE, Ito C,
Zandstra PW (2012) Rapid expansion of human hematopoietic stem cells
by automated control of inhibitory feedback signaling. Cell Stem Cell 10:
218 – 229
Csaszar E, Wang W, Usenko T, Qiao W, Delaney C, Bernstein ID, Zandstra PW
(2014) Blood stem cell fate regulation by Delta-1-mediated rewiring of
IL-6 paracrine signaling. Blood 123: 650 – 658
Danet GH, Lee HW, Luongo JL, Simon MC, Bonnet DA (2001) Dissociation
between stem cell phenotype and NOD/SCID repopulating activity in
human peripheral blood CD34(+) cells after ex vivo expansion. Exp
Hematol 29: 1465 – 1473
De Haan G, Weersing E, Dontje B, van Os R, Bystrykh LV, Vellenga E, Miller G
(2003) In vitro generation of long-term repopulating hematopoietic stem
cells by fibroblast growth factor-1. Dev Cell 4: 241 – 251
Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe
V, Le Bourhis X, Boilly B, Peyrat JP, Hondermarck H (2001) Nerve
growth factor stimulates proliferation and survival of human breast
cancer cells through two distinct signaling pathways. J Biol Chem 276:
17864 – 17870
Dhillon IS (2001) Co-clustering documents and words using bipartite spectral
graph partitioning. In Proceedings of the Seventh ACM SIGKDD International
Molecular Systems Biology 10: 741 | 2014 ª 2014 The Authors
Molecular Systems Biology Hematopoietic cell–cell communication network Wenlian Qiao et al
16
Conference on Knowledge Discovery and Data Mining, pp 269 – 274. New
York, NY, USA: ACM
Ding L, Saunders TL, Enikolopov G, Morrison SJ (2012) Endothelial and
perivascular cells maintain haematopoietic stem cells. Nature 481: 457 –462
Dorrell C, Gan OI, Pereira DS, Hawley RG, Dick JE (2000) Expansion of human
cord blood CD34(+)CD38() cells in ex vivo culture during retroviral
transduction without a corresponding increase in SCID repopulating cell
(SRC) frequency: dissociation of SRC phenotype and function. Blood 95:
102 – 110
Edgar R, Domrachev M, Lash AE (2002) Gene expression Omnibus: NCBI gene
expression and hybridization array data repository. Nucleic Acids Res 30:
207 – 210
Frankenstein Z, Alon U, Cohen IR (2006) The immune-body cytokine network
defines a social architecture of cell interactions. Biol Direct 1: 32
Gower JC, Legendre P (1986) Metric and Euclidean properties of dissimilarity
coefficients. J Classif 3: 5 – 48
Gu L, Chiang K-Y, Zhu N, Findley HW, Zhou M (2007) Contribution of STAT3
to the activation of survivin by GM-CSF in CD34+ cell lines. Exp Hematol
35: 957 – 966
Harel-Bellan A, Farrar W (1987) Modulation of proto-oncogene expression
by colony stimulating factors. Biochem Biophys Res Commun 148:
1001 – 1008
Heazlewood SY, Neaves RJ, Williams B, Haylock DN, Adams TE, Nilsson SK
(2013) Megakaryocytes co-localise with hemopoietic stem cells and release
cytokines that up-regulate stem cell proliferation. Stem Cell Res 11:
782 – 792
Hock H, Hamblen MJ, Rooke HM, Schindler JW, Saleque S, Fujiwara Y, Orkin
SH (2004) Gfi-1 restricts proliferation and preserves functional integrity of
haematopoietic stem cells. Nature 431: 1002 – 1007
Holien T, Våtsveen TK, Hella H, Rampa C, Brede G, Grøseth LAG, Rekvig M,
Børset M, Standal T, Waage A, Sundan A (2012) Bone morphogenetic
proteins induce apoptosis in multiple myeloma cells by Smad-dependent
repression of MYC. Leukemia 26: 1073 – 1080
Huang H, Cantor AB (2009) Common features of megakaryocytes and
hematopoietic stem cells: what’s the connection? J Cell Biochem 107:
857 – 864
Hughes DP, Marron MB, Brindle NPJ (2003) The antiinflammatory endothelial
tyrosine kinase Tie2 interacts with a novel nuclear factor-kappaB inhibitor
ABIN-2. Circ Res 92: 630 – 636
Ito CY, Kirouac DC, Madlambayan GJ, Yu M, Rogers I, Zandstra PW (2010) The
AC133+CD38, but not the rhodamine-low, phenotype tracks LTC-IC and
SRC function in human cord blood ex vivo expansion cultures. Blood 115:
257 – 260
Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB (2005) A
systems model of signaling identifies a molecular basis set for
cytokine-induced apoptosis. Science 310: 1646 – 1653
Jeong H, Mason SP, Barabasi AL, Oltvai ZN (2001) Lethality and centrality in
protein networks. Nature 411: 41 – 42
Kale VP (2004) Differential activation of MAPK signaling pathways by
TGF-beta1 forms the molecular mechanism behind its dose-dependent
bidirectional effects on hematopoiesis. Stem Cells Dev 13: 27 – 38
Kasprzyk A (2011) BioMart: driving a paradigm change in biological data
management. Database (Oxford) 2011: 1 – 3
Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, Enokimura N,
Yamamoto N, Okano H, Sugimoto K, Murata K, Nakano T (2004)
Functional expression of TWEAK in human hepatocellular carcinoma:
possible implication in cell proliferation and tumor angiogenesis. Biochem
Biophys Res Commun 318: 726 – 733
Kirito K, Fox N, Komatsu N, Kaushansky K (2005) Thrombopoietin enhances
expression of vascular endothelial growth factor (VEGF) in primitive
hematopoietic cells through induction of HIF-1 alpha. Blood 105:
4258 – 4263
Kirouac DC, Madlambayan GJ, Yu M, Sykes EA, Ito C, Zandstra PW (2009)
Cell-cell interaction networks regulate blood stem and progenitor cell fate.
Mol Syst Biol 5: 293
Kirouac DC, Ito C, Csaszar E, Roch A, Yu M, Sykes EA, Bader GD, Zandstra PW
(2010) Dynamic interaction networks in a hierarchically organized tissue.
Mol Syst Biol 6: 417
Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A
(2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and
caspase-8 to death receptors 4 and 5. Immunity 12: 611 – 620
Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T,
Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS (2013) Arteriolar
niches maintain haematopoietic stem cell quiescence. Nature 502:
637 – 643
Laurenti E, Doulatov S, Zandi S, Plumb I, Chen J, April C, Fan J-B, Dick JE
(2013) The transcriptional architecture of early human hematopoiesis
identifies multilevel control of lymphoid commitment. Nat Immunol 14:
756 – 763
Madlambayan GJ, Rogers I, Kirouac DC, Yamanaka N, Mazurier F, Doedens
M, Casper RF, Dick JE, Zandstra PW (2005) Dynamic changes in
cellular and microenvironmental composition can be controlled to elicit
in vitro human hematopoietic stem cell expansion. Exp Hematol 33:
1229 – 1239
Mallick S, Pal BC, Vedasiromoni JR, Kumar D, Saha KD (2012) Corchorusin-D
directed apoptosis of K562 cells occurs through activation of
mitochondrial and death receptor pathways and suppression of AKT/PKB
pathway. Cell Physiol Biochem 30: 915 – 926
Mayani BH, Lansdorp PM (1994) Thy-1 expression is linked to functional
properties of primitive hematopoietic progenitor cells from human
umbilical cord blood. Blood 83: 2410 – 2417
McKinney-Freeman S, Cahan P, Li H, Lacadie SA, Huang H-T, Curran M,
Loewer S, Naveiras O, Kathrein KL, Konantz M, Langdon EM, Lengerke C,
Zon LI, Collins JJ, Daley GQ (2012) The transcriptional landscape of
hematopoietic stem cell ontogeny. Cell Stem Cell 11: 701 – 714
Muller CB, Adriaanse ICT, Belshaw R, Godfray HCJ (1999) The structure of an
aphid-parasitoid community. J Anim Ecol 68: 346 – 370
Nagasawa T (2007) The chemokine CXCL12 and regulation of HSC and B
lymphocyte development in the bone marrow niche. Adv Exp Med Biol
602: 69 – 75
Nakamura Y, Arai F, Iwasaki H, Hosokawa K, Kobayashi I, Gomei Y,
Matsumoto Y, Yoshihara H, Suda T (2010) Isolation and characterization
of endosteal niche cell populations that regulate hematopoietic stem cells.
Blood 116: 1422 – 1432
Nombela-Arrieta C, Pivarnik G, Winkel B, Canty KJ, Harley B, Mahoney JE, Park
S-Y, Lu J, Protopopov A, Silberstein LE (2013) Quantitative imaging of
haematopoietic stem and progenitor cell localization and hypoxic status
in the bone marrow microenvironment. Nat Cell Biol 15: 533 – 543
Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE (2011) Isolation of
single human hematopoietic stem cells capable of long-term multilineage
engraftment. Science 333: 218 – 221
Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey
ME, Habib N, Yosef N, Chang CY, Shay T, Frampton GM, Drake AC, Leskov
I, Nilsson B, Preffer F, Dombkowski D, Evans JW, Liefeld T, Smutko JS, Chen
J et al (2011) Densely interconnected transcriptional circuits control cell
States in human hematopoiesis. Cell 144: 296 – 309
ª 2014 The Authors Molecular Systems Biology 10: 741 | 2014
Wenlian Qiao et al Hematopoietic cell–cell communication network Molecular Systems Biology
17
Olesen JM, Bascompte J, Dupont YL, Jordano P (2007) The modularity of
pollination networks. Proc Natl Acad Sci USA 104: 19891 – 19896
Petzer AL, Zandstra PW, Piret JM, Eaves CJ (1996) Differential cytokine effects
on primitive (CD34+CD38) human hematopoietic cells: novel responses
to Flt3-ligand and thrombopoietin. J Exp Med 183: 2551 – 2558
Qiao W, Quon G, Csaszar E, Yu M, Morris Q, Zandstra PW (2012) PERT: a
method for expression deconvolution of human blood samples from
varied microenvironmental and developmental conditions. PLoS Comput
Biol 8: e1002838
Robb L (2007) Cytokine receptors and hematopoietic differentiation. Oncogene
26: 6715 – 6723
Rousseeuw PJ (1987) Silhouettes: a graphical aid to the interpretation and
validation of cluster analysis. J Comput Appl Math 20: 53 – 65
Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ,
Hsiao EC, Passegue E (2013) Myeloproliferative neoplasia remodels the
endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell
Stem Cell 13: 285 – 299
Shimodaira H (2002) An approximately unbiased test of phylogenetic tree
selection. Syst Biol 51: 492 – 508
Shimodaira H (2004) Approximately unbiased tests of regions using
multistep-multiscale boot-strap resamping. Ann Stat 32: 2616 – 2641
Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W,
Selbach M (2011) Global quantification of mammalian gene expression
control. Nature 473: 337 – 342
Shima Y, Nakao K, Nakashima T, Kawakami A, Nakata K, Hamasaki K, Kato Y,
Eguchi K, Ishii N (1999) Activation of caspase-8 in transforming growth
factor-beta-induced apoptosis of human hepatoma cells. Hepatology 30:
1215 – 1222
Soni S, Bala S, Hanspal M (2008) Requirement for erythroblast-macrophage
protein (Emp) in definitive erythropoiesis. Blood Cells. Mol Dis 41:
141 – 147
Stein SJ, Baldwin AS (2013) Deletion of the NF-jB subunit p65/RelA in the
hematopoietic compartment leads to defects in hematopoietic stem cell
function. Blood 121: 5015 – 5024
Takizawa H, Boettcher S, Manz MG (2012) Demand-adapted regulation of
early hematopoiesis in infection and inflammation. Blood 119: 2991 – 3002
Turner B, Razick S, Turinsky AL, Vlasblom J, Crowdy EK, Cho E, Morrison K,
Donaldson IM, Wodak SJ (2010) iRefWeb: interactive analysis of
consolidated protein interaction data and their supporting evidence.
Database (Oxford) 2010: baq023
Vitali S, Glattfelder JB, Battiston S (2011) The network of global corporate
control. PLoS ONE 6: e25995
Yoshizaki A, Nakayama T, Yamazumi K, Yakata Y, Taba M, Sekine I (2006)
Expression of interleukin (IL)-11 and IL-11 receptor in human
colorectal adenocarcinoma: IL-11 up-regulation of the invasive and
proliferative activity of human colorectal carcinoma cells. Int J Oncol 29:
869 – 876
Zamai L, Secchiero P, Pierpaoli S, Bassini A, Papa S, Alnemri ES, Guidotti L,
Vitale M, Zauli G (2000) TNF-related apoptosis-inducing ligand (TRAIL) as
a negative regulator of normal human erythropoiesis. Blood 95:
3716 – 3724
Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T,
Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L (2003) Identification of
the haematopoietic stem cell niche and control of the niche size. Nature
425: 836 – 841
Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D,
Porter-Westpfahl KS, Wiedemann LM, Wu H, Li L (2006) PTEN maintains
haematopoietic stem cells and acts in lineage choice and leukaemia
prevention. Nature 441: 518 – 522
Zhao C, Xiu Y, Ashton J, Xing L, Morita Y, Jordan CT, Boyce BF (2012)
Noncanonical NF-jB signaling regulates hematopoietic stem cell
self-renewal and microenvironment interactions. Stem Cells 30: 709 – 718
License: This is an open access article under the
terms of the Creative Commons Attribution 4.0
License, which permits use, distribution and reproduc-
tion in any medium, provided the original work is
properly cited.
Molecular Systems Biology 10: 741 | 2014 ª 2014 The Authors
Molecular Systems Biology Hematopoietic cell–cell communication network Wenlian Qiao et al
18
